592 resources
Rows 0 - 200 Next
| Package | Identity | Name/Title | Status | FMM | WG | Date | Realm | Resource |
|---|---|---|---|---|---|---|---|---|
| hl7.fhir.pl.ssidl | ssidl-activityDefinition-labServiceDefinition | Definicja usługi laboratoryjnej w bazie wiedzy (SSIDL) | draft | 2025-08 | pl | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | body-positioning-action | Body Positioning Action | draft | 2022-09 | uv | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | drug-administration-action | Drug Administration Action | draft | 2022-09 | uv | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | procedure-action | Procedure Action | draft | 2024-05 | uv | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | recommendation-action | Recommendation Action | draft | 2021-12 | uv | ActivityDefinition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | assessment-action | Assessment Action | draft | 2023-11 | uv | ActivityDefinition | ||
| hl7.fhir.uv.pharm-quality | ActivityDefinition-test-drug-pq | ActivityDefinition - Test Drug PQ | active | brr | 2024-05 | uv | ActivityDefinition | |
| hl7.fhir.uv.order-catalog | LabProcedureDefinition | Laboratory Procedure Definition | trial-use | 2 | oo | 2025-06 | uv | ActivityDefinition |
| hl7.fhir.pl.ssidl | ssidl-activityDefinition-labCatalogService | Usługa katalogowa laboratorium (SSIDL) | draft | 2025-08 | pl | ActivityDefinition | ||
| hl7.eu.fhir.unicom | PPLAdministrableProductDefinition | PPL Administrable Product profile | draft | 2025-06 | eu | AdministrableProductDefinition | ||
| hl7.fhir.uv.emedicinal-product-info | AdministrableProductDefinition-uv-epi | AdministrableProductDefinition (ePI) | trial-use | 2 | 2025-07 | uv | AdministrableProductDefinition | |
| hl7.eu.fhir.unicom | TransitionAdministrableProductDefinition | Processing Profile - Administrable Product | draft | 2025-06 | eu | AdministrableProductDefinition | ||
| ch.fhir.ig.ch-epl | ch-idmp-administrableproductdefinition | CH IDMP AdministrableProductDefinition | active | 2025-05 | ch | AdministrableProductDefinition | ||
| hl7.fhir.uv.adverseeventclinicalcare | AdverseEvent-clinical-care | Adverse Event Clinical Care | informative | 1 | 2022-06 | uv | AdverseEvent | |
| hl7.fhir.eu.imaging-manifest-r5 | ImAdverseEvent | Imaging Adverse Event | draft | 1 | 2025-07 | eu | AdverseEvent | |
| hl7.fhir.eu.imaging-r5 | ImAdverseEvent | Imaging Adverse Event | draft | 1 | 2025-08 | eu | AdverseEvent | |
| hl7.fhir.uv.ae-research-ig | AdverseEvent-clinical-research | Adverse Event Clinical Research | trial-use | 2 | brr | 2024-04 | uv | AdverseEvent |
| hl7.fhir.eu.imaging-r5 | Report-ImAdverseEvent | Report obligations for ImAdverseEvent | draft | 2025-08 | eu | AdverseEvent | ||
| hl7.fhir.eu.imaging-manifest-r5 | AllergyIntoleranceEu | EU AllergyIntolerance | draft | 1 | 2025-07 | eu | AllergyIntolerance | |
| hl7.fhir.eu.imaging-r5 | AllergyIntoleranceEu | EU AllergyIntolerance | draft | 1 | 2025-08 | eu | AllergyIntolerance | |
| hl7.fhir.cr.core | allergy-intolerance-cr-core | Alergias e Intolerancias | draft | 0 | cgp | 2025-03 | cr | AllergyIntolerance |
| hl7.fhir.eu.imaging-r5 | Report-EuAllergyIntolerance | Report obligations for EuAllergyIntolerance | draft | 2025-08 | eu | AllergyIntolerance | ||
| hl7.at.fhir.tc.wg.scheduling.r5 | at-scheduling-appointment | HL7® AT Scheduling Appointment Profile | draft | 2025-05 | Appointment | |||
| de.netzwerk-universitaetsmedizin.ebm-cpg | recommendation-justification | Recommendation Justification | draft | 2022-03 | uv | ArtifactAssessment | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | certainty-of-evidence-rating | Certainty of Evidence Rating | draft | 2022-03 | uv | ArtifactAssessment | ||
| hl7.fhir.cr.core | audit-event-cr-core | Auditoría de Eventos | draft | 0 | cgp | 2025-03 | cr | AuditEvent |
| hl7.fhir.eu.imaging-manifest-r5 | BodyStructureEu | EU BodyStructure | draft | 1 | 2025-07 | eu | BodyStructure | |
| hl7.fhir.eu.imaging-r5 | BodyStructureEu | EU BodyStructure | draft | 1 | 2025-08 | eu | BodyStructure | |
| hl7.fhir.uv.dicom-sr | dicom-sr-finding-site | Body Structure - DICOM SR Finding Site Mapping | active | ii | 2025-05 | uv | BodyStructure | |
| hl7.fhir.uv.dicom-sr | dicom-sr-tracking-identifiers | Body Structure - DICOM SR Observation Tracking Identifier Mapping | active | ii | 2025-05 | uv | BodyStructure | |
| hl7.fhir.eu.imaging-manifest-r5 | Manifest-EuBodyStructure | Manifest obligations for EuBodyStructure | draft | 2025-07 | eu | BodyStructure | ||
| hl7.fhir.eu.imaging-r5 | Manifest-EuBodyStructure | Manifest obligations for EuBodyStructure | draft | 2025-08 | eu | BodyStructure | ||
| hl7.fhir.eu.imaging-r5 | Report-EuBodyStructure | Report obligations for EuBodyStructure | draft | 2025-08 | eu | BodyStructure | ||
| hl7.fhir.eu.base-r5 | bodyStructure-eu | BodyStructure (EU base) | draft | 2 | 2025-08 | eu | BodyStructure | |
| hl7.fhir.us.spl | OrganizationBundle | OrganizationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | GDUFAFacilityIdentificationBundle | GDUFAFacilityIdentificationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | LabelerInactivationBundle | LabelerInactivationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | LabelerCodeRequestBundle | LabelerCodeRequestBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | NoChangeNotificationBundle | NoChangeNotificationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | EstablishmentRegistrationBundle | EstablishmentRegistrationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | EstablishmentInactivationBundle | EstablishmentInactivationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | GDUFAFacilityInactivationBundle | GDUFAFacilityInactivationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | OutOfBusinessBundle | OutOfBusinessBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.spl | ProductSubmissionBundle | ProductSubmissionBundle | trial-use | 1 | brr | 2025-07 | us | Bundle |
| hl7.fhir.uv.pharm-quality | Bundle-analytical-procedure-pq | Bundle – Analytical Procedure PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-batch-analysis-pq | Bundle – Batch Analysis PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-batch-formula-pq | Bundle – Batch Formula PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-batch-info-pq | Bundle – drug Product Batch Information PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-batch-info-pq | Bundle – Drug Substance Batch Information PQ | active | brr | 2024-05 | uv | Bundle | |
| de.netzwerk-universitaetsmedizin.ebm-cpg | guideline-bundle | Guideline Bundle | draft | 2022-12 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-compatibility-pq | Bundle - Drug Product Compatibility PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-reference-standards-pq | Bundle – Drug Reference Standards PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-composition-pq | Bundle – Drug Product Composition PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-container-closure-system-pq | Bundle – Container Closure System PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p10 | CMC eCTD 32P10 Document | trial-use | 2 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p32 | CMC eCTD 32P32 Document | trial-use | 2 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32p55 | CMC eCTD 32P55 Document | trial-use | 2 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s10 | CMC eCTD 32S10 Document | trial-use | 2 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s23 | CMC eCTD 32S23 Document | trial-use | 2 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-32s3 | CMC eCTD 32S3 Document | trial-use | 2 | brr | 2025-07 | us | Bundle |
| hl7.fhir.us.pq-cmc-fda | cmc-ectd-document-sp4151 | CMC eCTD SP4151 Document | trial-use | 2 | brr | 2025-07 | us | Bundle |
| hl7.fhir.eu.imaging-manifest-r5 | ImReport | Document Bundle for Imaging Report | draft | 1 | 2025-07 | eu | Bundle | |
| hl7.fhir.eu.imaging-r5 | ImReport | Document Bundle for Imaging Report | draft | 1 | 2025-08 | eu | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-pq | Bundle - Drug Product PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-microbiological-attributes-pq | Bundle – Drug Product Microbiological Attributes PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-excipients-pq | Bundle – Drug Product Excipients PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-general-properties-pq | Bundle – Drug Substance General Properties PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-characterization-pq | Bundle – Drug Substance Characterization PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-product-impurities-pq | Bundle - Product Impurities PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.eu.imaging-manifest-r5 | Manifest-ImImagingStudyManifest | Manifest obligations for ImImagingStudyManifest | draft | 2025-07 | eu | Bundle | ||
| hl7.fhir.eu.imaging-r5 | Manifest-ImImagingStudyManifest | Manifest obligations for ImImagingStudyManifest | draft | 2025-08 | eu | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-product-manufacturing-pq | Bundle - Product Manufacturing PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.emedicinal-product-info | Bundle-uv-epi | Bundle - ePI | trial-use | 2 | 2025-07 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-organizations-pq | Bundle - Organizations PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.pl.ssidl | ssidl-bundle-labExport | Pakiet eksportu laboratorium (SSIDL) | draft | 2025-08 | pl | Bundle | ||
| hl7.fhir.pl.ssidl | ssidl-bundle-serviceCatalog | Pakiet katalogu usług (SSIDL) | draft | 2025-08 | pl | Bundle | ||
| hl7.fhir.cr.core | bundle-cr-core | Paquete de Recursos | draft | 0 | cgp | 2025-03 | cr | Bundle |
| hl7.eu.fhir.gh | persona-collection | Persona Dimension Collection | active | 2025-07 | eu | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-product-process-validation-pq | Bundle - Product Process Validation PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.recon-ig | apix-transaction-bundle-profile | APIX Transaction Bundle Profile | draft | 2025-07 | uv | Bundle | ||
| ch.fhir.ig.ch-epl | ch-idmp-bundle | IDMP Bundle | active | 2025-05 | ch | Bundle | ||
| hl7.fhir.eu.imaging-r5 | Report-ImReport | Report obligations for ImReport | draft | 2025-08 | eu | Bundle | ||
| hl7.fhir.uv.pharm-quality | Bundle-drug-product-specification-pq | Bundle – Drug Product Specification PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-substance-specification-pq | Bundle – Drug Substance Specification PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | Bundle-drug-stability-pq | Bundle – Drug Stability PQ | active | brr | 2024-05 | uv | Bundle | |
| hl7.fhir.uv.order-catalog | ItemTransactionResponse | Catalog Item Transaction Request | trial-use | 2 | oo | 2025-06 | uv | Bundle |
| hl7.fhir.uv.order-catalog | ItemTransactionRequest | Catalog Item Transaction Request | trial-use | 2 | oo | 2025-06 | uv | Bundle |
| hl7.fhir.eu.imaging-manifest-r5 | ImImagingStudyManifest | IM ImagingStudy Manifest | draft | 1 | 2025-07 | eu | Bundle | |
| hl7.fhir.eu.imaging-r5 | ImImagingStudyManifest | IM ImagingStudy Manifest | draft | 1 | 2025-08 | eu | Bundle | |
| ru.fhir.semd | semd-bundle | SEMD Bundle (Пакет СЭМД) | active | 2025-07 | Bundle | |||
| hl7.fhir.uv.application-feature | FeatureCapabilityStatement | Feature Capability Statement | trial-use | 1 | fhir | 2025-05 | uv | CapabilityStatement |
| hl7.fhir.eu.imaging-manifest-r5 | CarePlanEu | EU CarePlan | draft | 1 | 2025-07 | eu | CarePlan | |
| hl7.fhir.eu.imaging-r5 | CarePlanEu | EU CarePlan | draft | 1 | 2025-08 | eu | CarePlan | |
| hl7.fhir.eu.imaging-r5 | Report-EuCarePlan | Report obligations for EuCarePlan | draft | 2025-08 | eu | CarePlan | ||
| ru.core | core-careteam | Core CareTeam (Бригада) | active | 2025-08 | CareTeam | |||
| ru.fhir.semd | core-careteam | Core CareTeam (Бригада) | active | 2025-07 | CareTeam | |||
| ru.fhir.semd | semd-careteam | SEMD CareTeam (Бригада) | active | 2025-07 | CareTeam | |||
| hl7.fhir.uv.order-catalog | LabChargeItemDefinition | Laboratory Service Charge Item Definition | trial-use | 2 | oo | 2020-02 | uv | ChargeItemDefinition |
| de.netzwerk-universitaetsmedizin.ebm-cpg | guideline-citation | Guideline Citation | draft | 2022-03 | uv | Citation | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | recommendation-citation | Recommendation Citation | draft | 2022-03 | uv | Citation | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | study-citation | Study Citation | draft | 2022-03 | uv | Citation | ||
| hl7.fhir.pl.ssidl | ssidl-citation-sourceInfo | Źródło (SSIDL) | draft | 2025-08 | pl | Citation | ||
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-contraindication-uv-epi | ClinicalUseDefinition Contraindication (ePI) | trial-use | 2 | 2025-07 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-indication-uv-epi | ClinicalUseDefinition Indication (ePI) | trial-use | 2 | 2025-07 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-interaction-uv-epi | ClinicalUseDefinition Interaction (ePI) | trial-use | 2 | 2025-07 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-undesirableEffect-uv-epi | ClinicalUseDefinition Undesirable Effect (ePI) | trial-use | 2 | 2025-07 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.emedicinal-product-info | ClinicalUseDefinition-warning-uv-epi | ClinicalUseDefinition Warning (ePI) | trial-use | 2 | 2025-07 | uv | ClinicalUseDefinition | |
| ch.fhir.ig.ch-epl | ch-idmp-clinicalusedefinition-indication | CH IDMP ClinicalUseDefinition Indication | active | 2025-05 | ch | ClinicalUseDefinition | ||
| hl7.fhir.uv.order-catalog | ContraindicationDefinition | ClinicalUseDefinition as a contraindication | trial-use | 2 | oo | 2025-06 | uv | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | WarningDefinition | ClinicalUseDefinition as a warning | trial-use | 2 | oo | 2025-06 | uv | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | IndicationDefinition | ClinicalUseDefinition as a therapeutic indication | trial-use | 2 | oo | 2025-06 | uv | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | InteractionDefinition | ClinicalUseDefinition as an interaction | trial-use | 2 | oo | 2025-06 | uv | ClinicalUseDefinition |
| hl7.fhir.uv.order-catalog | UndesirableEffectDefinition | ClinicalUseDefinition as an undesirable effect | trial-use | 2 | oo | 2025-06 | uv | ClinicalUseDefinition |
| hl7.fhir.pl.ssidl | ssidl-codeSystem | Słownik (SSIDL) | draft | 2025-08 | pl | CodeSystem | ||
| hl7.fhir.uv.rfi-ig | RFICommunication | RFICommunication | draft | 2025-06 | uv | Communication | ||
| hl7.fhir.us.spl | ProductSubmissionDocument | ProductSubmissionDocument | trial-use | 1 | brr | 2025-07 | us | Composition |
| hl7.fhir.eu.imaging-manifest-r5 | ImComposition | Imaging Composition | draft | 1 | 2025-07 | eu | Composition | |
| hl7.fhir.eu.imaging-r5 | ImComposition | Imaging Composition | draft | 1 | 2025-08 | eu | Composition | |
| hl7.fhir.eu.imaging-manifest-r5 | CompositionEu | EU Composition | draft | 1 | 2025-07 | eu | Composition | |
| hl7.fhir.eu.imaging-r5 | CompositionEu | EU Composition | draft | 1 | 2025-08 | eu | Composition | |
| Hl7PlBaseIg | pl-base-composition | Composition (PL) | draft | 2025-08 | Composition | |||
| hl7.eu.fhir.gh | focusedcomposition | Focused Composition Profile | active | 2025-07 | eu | Composition | ||
| hl7.fhir.cr.core | composition-cr-core | Documento Clínico | draft | 0 | cgp | 2025-03 | cr | Composition |
| hl7.fhir.eu.imaging-r5 | Report-ImComposition | Report obligations for ImComposition | draft | 2025-08 | eu | Composition | ||
| de.netzwerk-universitaetsmedizin.ebm-cpg | guideline | Clinical Practice Guideline | draft | 2022-12 | uv | Composition | ||
| hl7.eu.fhir.gh | SummaryData | Summary Data Profile | active | 2025-07 | eu | Composition | ||
| hl7.fhir.uv.emedicinal-product-info | Composition-uv-epi | Composition (ePI) | trial-use | 2 | 2025-07 | uv | Composition | |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-sp4151 | eCTD Specification | trial-use | 2 | brr | 2025-07 | us | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p32 | eCTD Batch Formula | trial-use | 2 | brr | 2025-07 | us | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p55 | eCTD Product Characterisation of Impurities | trial-use | 2 | brr | 2025-07 | us | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32p10 | eCTD Product Description and Composition | trial-use | 2 | brr | 2025-07 | us | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s23 | eCTD Substance Control of Materials | trial-use | 2 | brr | 2025-07 | us | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s10 | eCTD Substance General Information | trial-use | 2 | brr | 2025-07 | us | Composition |
| hl7.fhir.us.pq-cmc-fda | ectd-composition-32s3 | eCTD Substance Characterisation | trial-use | 2 | brr | 2025-07 | us | Composition |
| hl7.fhir.uv.pharm-quality | Composition-drug-pq | Composition - Drug PQ | active | brr | 2024-05 | uv | Composition | |
| hl7.fhir.uv.order-catalog | Catalog | Catalog | draft | oo | 2025-06 | uv | Composition | |
| hl7.fhir.uv.order-catalog | CatalogHeader | Catalog Header | draft | oo | 2025-06 | uv | Composition | |
| ru.core | core-composition | Core Composition (Документ) | active | 2025-08 | Composition | |||
| ru.fhir.semd | core-composition | Core Composition (Документ) | active | 2025-07 | Composition | |||
| ru.fhir.semd | pli-semd-composition | PLI SEMD Composition (Состав СЭМД ПЛИ) | active | 2025-07 | Composition | |||
| ru.fhir.semd | semd-composition | SEMD Composition (Состав СЭМД) | active | 2025-07 | Composition | |||
| hl7.fhir.eu.imaging-manifest-r5 | ConditionEu | EU Condition | draft | 1 | 2025-07 | eu | Condition | |
| hl7.fhir.eu.imaging-r5 | ConditionEu | EU Condition | draft | 1 | 2025-08 | eu | Condition | |
| hl7.fhir.cr.core | condition-cr-core | Condición | draft | 0 | cgp | 2025-03 | cr | Condition |
| hl7.fhir.eu.imaging-r5 | Report-EuCondition | Report obligations for EuCondition | draft | 2025-08 | eu | Condition | ||
| hl7.fhir.pl.ssidl | ssidl-conditionDefinition-reasonForTest | Cel badania (SSIDL) | draft | 2025-08 | pl | ConditionDefinition | ||
| Hl7PlBaseIg | pl-base-contract | Contract (PL) | draft | 2025-08 | Contract | |||
| hl7.fhir.eu.base-r5 | coverage-eu-ehic | Coverage (EHIC) | draft | 2 | 2025-08 | eu | Coverage | |
| Hl7PlBaseIg | pl-base-coverage | Coverage (PL) | draft | 2025-08 | Coverage | |||
| hl7.fhir.eu.imaging-r5 | Report-EuCoverage | Report obligations for EuCoverage | draft | 2025-08 | eu | Coverage | ||
| ru.core | core-coverage | Core Coverage (Страховое покрытие) | active | 2025-08 | Coverage | |||
| ru.fhir.semd | core-coverage | Core Coverage (Страховое покрытие) | active | 2025-07 | Coverage | |||
| ru.fhir.semd | semd-coverage | SEMD Coverage (Страховое покрытие СЭМД) | active | 2025-07 | Coverage | |||
| hl7.fhir.uv.cardx-cied | cied-device | Device - Cardiovascular Implantable Electronic Device (CIED) | trial-use | 2 | cic | 2025-07 | uv | Device |
| hl7.fhir.uv.cardx-cied | cied-monitor | Device - CIED Monitor Profile | trial-use | 2 | cic | 2025-07 | uv | Device |
| hl7.fhir.uv.dicom-sr | dicom-general-equipment | Device - DICOM General Equipment Mapping | active | ii | 2025-05 | uv | Device | |
| hl7.fhir.uv.dicom-sr | dicom-participant-device | Device - DICOM Participant Device Mapping | active | ii | 2025-05 | uv | Device | |
| hl7.fhir.uv.dicom-sr | algorithm-identification | Device - DICOM SR Algorithm Identification Mapping | active | ii | 2025-05 | uv | Device | |
| hl7.fhir.eu.imaging-manifest-r5 | Manifest-EuDevice | Manifest obligations for EuDevice | draft | 2025-07 | eu | Device | ||
| hl7.fhir.eu.imaging-r5 | Manifest-EuDevice | Manifest obligations for EuDevice | draft | 2025-08 | eu | Device | ||
| hl7.fhir.eu.imaging-r5 | Report-EuDevice | Report obligations for EuDevice | draft | 2025-08 | eu | Device | ||
| hl7.fhir.eu.imaging-manifest-r5 | ImImagingDevice | Im Imaging Device | draft | 1 | 2025-07 | eu | Device | |
| hl7.fhir.eu.imaging-r5 | ImImagingDevice | Im Imaging Device | draft | 1 | 2025-08 | eu | Device | |
| ru.fhir.semd | pli-semd-device | PLI SEMD Device (Устройство ПЛИ) | active | 2025-07 | Device | |||
| hl7.fhir.uv.pharm-quality | DeviceDefinition-drug-pq | DeviceDefinition - Drug PQ | active | brr | 2024-05 | uv | DeviceDefinition | |
| hl7.fhir.uv.order-catalog | DeviceModel | Device Model | trial-use | 2 | oo | 2022-02 | uv | DeviceDefinition |
| hl7.fhir.eu.imaging-manifest-r5 | ImDiagnosticReport | Imaging Diagnostic Report | draft | 1 | 2025-07 | eu | DiagnosticReport | |
| hl7.fhir.eu.imaging-r5 | ImDiagnosticReport | Imaging Diagnostic Report | draft | 1 | 2025-08 | eu | DiagnosticReport | |
| hl7.fhir.eu.imaging-r5 | Report-ImDiagnosticReport | Report obligations for ImDiagnosticReport | draft | 2025-08 | eu | DiagnosticReport | ||
| hl7.fhir.uv.pharm-quality | DiagnosticReport-analysis-drug-pq | DiagnosticReport - Analysis Drug PQ | active | brr | 2024-05 | uv | DiagnosticReport | |
| ru.core | core-diagnosticreport | Core DiagnosticReport (Протокол исследования) | active | 2025-08 | DiagnosticReport | |||
| ru.fhir.semd | core-diagnosticreport | Протокол исследования | active | 2025-07 | DiagnosticReport | |||
| ru.fhir.semd | semd-diagnosticreport | SEMD DiagnosticReport (Диагностический отчет СЭМД) | active | 2025-07 | DiagnosticReport | |||
| ru.fhir.semd | pli-semd-diagnosticreport | PLI SEMD DiagnosticReport (Диагностический отчет лабораторных исследований СЭМД) | active | 2025-07 | DiagnosticReport | |||
| hl7.fhir.us.pq-cmc-fda | pqcmc-graphic-reference | Graphic Reference | trial-use | 2 | brr | 2025-07 | us | DocumentReference |
| hl7.fhir.us.pq-cmc-fda | pqcmc-structure-reference | Structure Data Reference | trial-use | 2 | brr | 2025-07 | us | DocumentReference |
| hl7.fhir.eu.imaging-manifest-r5 | DocumentReferenceEu | DocumentReferenceEu | draft | 1 | 2025-07 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | DocumentReferenceEu | DocumentReferenceEu | draft | 1 | 2025-08 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-manifest-r5 | ImManifestIheMhdDocumentReference | Manifest DocumentReference for MHD deployments | draft | 1 | 2025-07 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | ImManifestIheMhdDocumentReference | Manifest DocumentReference for MHD deployments | draft | 1 | 2025-08 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-manifest-r5 | ImReportIheMhdDocumentReference | Report DocumentReference for MHD deployments | draft | 1 | 2025-07 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | ImReportIheMhdDocumentReference | Report DocumentReference for MHD deployments | draft | 1 | 2025-08 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-manifest-r5 | ImKeyImageDocumentReference | Imaging Key Image Document Reference | draft | 1 | 2025-07 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | ImKeyImageDocumentReference | Imaging Key Image Document Reference | draft | 1 | 2025-08 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-manifest-r5 | ImIheMhdDocumentReference | R5 DocumentReference for MHD deployments | draft | 1 | 2025-07 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | ImIheMhdDocumentReference | R5 DocumentReference for MHD deployments | draft | 1 | 2025-08 | eu | DocumentReference | |
| hl7.fhir.us.spl | SPLDocumentReference | SPLDocumentReference | trial-use | 1 | brr | 2025-07 | us | DocumentReference |
| hl7.fhir.us.pq-cmc-fda | cmc-document-reference | Document Reference Attachment | trial-use | 2 | brr | 2025-07 | us | DocumentReference |
| hl7.eu.fhir.gh | AdditionalSupportMaterial | Additional Support Material Profile | active | 2025-07 | eu | DocumentReference | ||
| hl7.fhir.eu.imaging-manifest-r5 | Manifest-ImManifestDocumentReference | Manifest Obligations for ImManifestIheMhdDocumentReference | draft | 1 | 2025-07 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | Manifest-ImManifestDocumentReference | Manifest Obligations for ImManifestIheMhdDocumentReference | draft | 1 | 2025-08 | eu | DocumentReference | |
| hl7.fhir.uv.recon-ig | apix-document-reference-profile | APIX DocumentReference Profile | draft | 2025-07 | uv | DocumentReference | ||
| ch.fhir.ig.ch-epl | ch-idmp-documentreference | CH IDMP DocumentReference | active | 2025-05 | ch | DocumentReference | ||
| hl7.fhir.eu.imaging-manifest-r5 | Report-ImReportDocumentReference | Report Obligations for ImReportIheMhdDocumentReference | draft | 1 | 2025-07 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | Report-ImReportDocumentReference | Report Obligations for ImReportIheMhdDocumentReference | draft | 1 | 2025-08 | eu | DocumentReference | |
| hl7.fhir.eu.imaging-r5 | Report-EuDocumentReference | Report obligations for EuDocumentReference | draft | 2025-08 | eu | DocumentReference | ||
| hl7.fhir.uv.pharm-quality | DocumentReference-drug-pq | DocumentReference - Drug PQ | active | brr | 2024-05 | uv | DocumentReference | |
| hl7.fhir.eu.imaging-manifest-r5 | EncounterEu | EU Encounter | draft | 1 | 2025-07 | eu | Encounter | |
| hl7.fhir.eu.imaging-r5 | EncounterEu | EU Encounter | draft | 1 | 2025-08 | eu | Encounter | |
| Hl7PlBaseIg | pl-base-encounter | Encounter (PL) | draft | 2025-08 | Encounter |